Investor Relations
Listed On The Shanghai Stock Exchange In June 2001, With A Maximum Market Value Of 47.5 Billion
Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on Resolutions of 2024 Third Extraordinary General Meeting
Time：2024-08-27
Ad hoc announcement pursuant to Art. 53 LR-JCARE Indicative Announcement on Acceptance of Application for Registration and Marketing Authorization of TG-1000 Capsule
Time：2024-08-12
Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on the Re-Election of the Board of Directors and the Supervisory Committee
Time：2024-08-06
Ad hoc announcement pursuant to Art. 53 LR-JCARE Notice of 2024 Third Extraordinary General Meeting
Time：2024-08-06
Ad hoc announcement pursuant to Art. 53 LR-Announcement on the Implementation of 2023 Profit Distribution of JCARE
Time：2024-07-11
Ad hoc announcement pursuant to Art. 53 LR-JCARE Indicative Announcement on Acceptance of Application for Registration and Marketing Authorization of Semaglutide Injection
Time：2024-06-12
Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on Obtaining Drug Registration Certificate for Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation
Time：2024-06-12
Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on Resolutions of 2023 Annual General Meeting
Time：2024-06-07
Ad hoc announcement pursuant to Art. 53 LR-JCARE Announcement on Obtaining Drug Registration Certificate
Time：2024-05-27
Ad hoc announcement pursuant to Art. 53 LR-JCARE Notice of 2023 Anuual General Meeting
Time：2024-05-17
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.